Insiders · ALXO

ALXO insider transactions

ALX Oncology Holdings Inc. (ALXO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ALXO

• 52d
  SEC Form 4 filed by Knight Jeff E.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 52d
  SEC Form 4 filed by Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 52d
  SEC Form 3 filed by new insider Knight Jeff E.

  3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 77d
  SEC Form 4 filed by Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 77d
  SEC Form 4 filed by Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 95d
  SEC Form 4 filed by Chief Medical Officer Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 95d
  New insider Klencke Barbara claimed ownership of 120,000 shares (SEC Form 3)

  3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 108d
  SVP, FINANCE AND CAO Pinto Shelly sold $1,283 worth of shares (565 units at $2.27), decreasing direct ownership by 0.64% to 87,708 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 109d
  CHIEF EXECUTIVE OFFICER Lettmann Jason covered exercise/tax liability with 2,201 shares, decreasing direct ownership by 0.71% to 305,920 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 124d
  Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 131d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 131d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 131d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 138d
  SEC Form 4 filed by Director Goodman Corey S

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 138d
  SEC Form 4 filed by Director Garland J. Scott

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 138d
  SEC Form 4 filed by Director Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 138d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 138d
  SEC Form 4 filed by Director Takimoto Chris H

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 138d
  SEC Form 4 filed by Director Curran Daniel J.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 152d
  SVP, FINANCE AND CAO Pinto Shelly sold $4,357 worth of shares (3,925 units at $1.11), decreasing direct ownership by 4% to 88,273 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 235d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 235d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 235d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 262d
  SEC Form 4 filed by Director Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 263d
  CHIEF EXECUTIVE OFFICER Lettmann Jason bought $99,352 worth of shares (92,233 units at $1.08), increasing direct ownership by 43% to 305,121 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 292d
  Chief Financial Officer Shantharam Harish bought $58,402 worth of shares (75,000 units at $0.78) (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 293d
  SVP, FINANCE AND CAO Pinto Shelly sold $391 worth of shares (611 units at $0.64), decreasing direct ownership by 0.68% to 89,198 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 293d
  CHIEF EXECUTIVE OFFICER Lettmann Jason sold $1,525 worth of shares (2,382 units at $0.64), decreasing direct ownership by 1% to 212,888 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 299d
  SEC Form 4 filed by Director Curran Daniel J.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 299d
  SEC Form 3 filed by new insider Curran Daniel J.

  3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 335d
  SVP, FINANCE AND CAO Pinto Shelly sold $905 worth of shares (2,011 units at $0.45), decreasing direct ownership by 2% to 86,809 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 342d
  SVP, FINANCE AND CAO Pinto Shelly sold $659 worth of shares (1,532 units at $0.43), decreasing direct ownership by 2% to 88,820 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 419d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 419d
  SEC Form 4 filed by Chief Medical Officer Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 419d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 419d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 447d
  SVP, FINANCE AND CAO Pinto Shelly was granted 3,000 shares, increasing direct ownership by 3% to 90,352 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 447d
  CHIEF EXECUTIVE OFFICER Lettmann Jason was granted 42,000 shares, increasing direct ownership by 25% to 212,270 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 472d
  SVP, FINANCE AND CAO Pinto Shelly sold $633 worth of shares (550 units at $1.15), decreasing direct ownership by 0.63% to 87,352 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 472d
  PRESIDENT & CSO Pons Jaume sold $1,525 worth of shares (1,326 units at $1.15), decreasing direct ownership by 0.23% to 579,388 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 472d
  CHIEF EXECUTIVE OFFICER Lettmann Jason sold $2,483 worth of shares (2,159 units at $1.15), decreasing direct ownership by 1% to 170,270 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Director Garland J. Scott

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Director Goodman Corey S

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Director Takimoto Chris H

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 3 filed by new insider Takimoto Chris H

  3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Director Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  New insider Klencke Barbara claimed ownership of 120,000 shares (SEC Form 3)

  3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 3 filed by new insider Shantharam Harish

  3 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by Chief Medical Officer Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by PRESIDENT & CSO Pons Jaume

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 501d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 516d
  Interim CFO Pinto Shelly sold $3,998 worth of shares (2,221 units at $1.80), decreasing direct ownership by 2% to 87,902 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 522d
  Interim CFO Pinto Shelly sold $2,253 worth of shares (1,426 units at $1.58), decreasing direct ownership by 2% to 90,123 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 522d
  PRESIDENT & CSO Pons Jaume sold $17,060 worth of shares (10,796 units at $1.58), decreasing direct ownership by 2% to 580,714 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 551d
  Director Hemrajani Rekha bought $46,404 worth of shares (30,000 units at $1.55), increasing direct ownership by 1,000% to 33,000 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 551d
  SEC Form 4 filed by Interim CFO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 551d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)